Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Diagnosis and Management of DHF and Dss

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 24

DIAGNOSIS AND

MANAGEMENT OF
DHF AND DSS
____________________
T.H. RAMPENGAN

Department of Child Health


Medical School Sam Ratulangi University
R.D.Kandou Hospital Manado

10/30/2019 1
INTRODUCTION
- DHF relatively new disease in Indonesia
- 1968 in Surabaya and Jakarta
- 1973 in Manado
- Management divided in DHF and DSS
- Mortality rate in : 1968 → 41.3%
1992 → 2.9 %
1995 → 2.5 %
2
DIAGNOSIS WHO 1975 /1986
Based on 4 clinical and 2 laboratoric
criteria
Clinical:
- High fever 2-7 days
- Hemorrhagic manifestation
- Hepatomegaly
- Shock
Laboratoric
- Thrombocytopenia
- Hemoconcentration
DX : Minimally 2 clinical + Lab criteria
The accuracy : 75-90%
3
The severity of disease divided in 4
grade

 I : Fever + non spesific + RL (+)


 II : I + other hemorrh manifest
 III : II + mild shock
 IV : III + severe shock
 Grade I+II : DHF
III+IV : DSS

4
 DHF : - ↑ permeability
- Fever ↓ → crisis
 DHF I, II :
- Crisis days III >
- IVFD 12 - 24 hours
- PCV ↑, Tr ↓ < 50 000
- Health center / >

5
Fever phase

- Oral fluid : 50 ml/kgBW for 4-6 hours


- IVFD maintenance : 80-100 ml/kg/days
- Antipyretic : Paracetamol 10 mg/kgBW/time
- Convulsion : Phenobarbital 5 mg/kgBW/days
- Critical Ill : Days 3-5

6
SUBSTITUTION FLUID IN DHF
Maintenance + 5 - 8%
 Vomiting every time
 Cannot drink
 ↑ fever
 PCV ↑ periodically
 Acidosis : NaBic
 PCV ↑ > 20% → IVFD : GED mild - mod

7
Table 1. Fluid need for
moderate dehydration
Body Weight Amount of fluid
(Kg) (ml/kgBW/day)

<7 220
7-11 165
12-18 132
>18 88

8
Table 2. Fluid need for maintenance
Body Weight (kg) Amount of fluid
(ml/kgBW/day)

<10 100/kgBW
10-20 1000 + 50/kgBW(>10kg)
>20 1500 +20/kgBW(>20 kg)

Example : 40 Kg = 1500 +(20x20) = 1900 ml

9
 Temperature ↓ → ↑ leakage
 Reconvalescen → Reabsorbtion of fluid
 Sign + symptom of shock → hospitalization
 Fluid Recommended (WHO)
- Cristaloid: RL-RL- D5%
RA - RA - D5%
NaCl 0,9% - NaCl 0,9% - D5%
- Colloid : Dextran L40
Plasma

10
DSS
 Shock→ emergency - fluid →recovery 48 hours
 Replacement of plasma volume
- Crystalloid: 20 ml/kgBW/30 min
- Still Shock : Colloid 10-20 ml/kgBW/h
Maximal 30 ml/kgBW
- Improvement : Crystalloid 10-20 ml/kgBW/h
- Still shock, PCV↓ → bleeding → blood
- PCV > 40 → blood 10 ml/kgBW/h
- Massive bleeding → blood 20 ml/kgBW/h
- Improvement → Crystalloid

11
Figure 1. Management of suspect DHF
Suspect DHF

Sudden high fever


continuously <7 d
URTI (-)

Emergency (+) Emergency (-)

Shock
Torniquet (+) Torniquet (-)
Vomit
Convulsion
Consiousness ↓ Trombocyte Trombocyte
Ambulatory
Hematemesis < 100000/µl > 100000/µl
Paracetamol
Melena
Control until fever ↓
Hospitalization Ambulatory

Follow up clinical & lab


Attention for parents Much drink
while days 3th fever (+)
Shock sign Paracetamol
Control until fever (-)
12
Figure 2. Management of DHF (Grade II)
Initial Fluid RL/NaCl 0.9% / RLD5/NaCl 0.9% + D5
(6-7 ml/kgBW/H)

Improvement (+) Monitoring vital sign / Improvement (-)


PCV and Trombocyte / 6H
Restlessness (-) Restlessness
Strong pulse Resp Distres
Stable BP Vital sign decrease Pulse rate ↑
Diuresis 2 ml/kbBW/H PCV ↑ BP ≤ 20 mmHg
PCV ↓ 2x exam Diuresis ↓/-

Decreased IV drip Improvement Increased IV drip

5 ml/kgBW/H 10 ml/kgBW/H
Evaluation 12-24 H
Step by step
Improvement (+)
15 ml/kgBW/H
3 ml/kgBW/H
Resp Distres Unstable vital sign PCV ↓
PCV ↑
IVFD Stop (24-48)
Colloid Fresh WB
If Vital Sign / PCV
/ Diuresis stable 20-30 ml/kgBW/H 10 ml/kgBW

Improvement
13
Figure 3. Management of DSS (Grade III and IV)
1. Oxygenation
DHF Gr III 2. Plasma volume replacement DHF Gr IV
RL/NaCl  20 ml/kgBW immediately (bolus 30 min)

Shock (-) Evaluation 30 min Shock (+)


Follow up vital sign every 10 min
Improvement consiousness Record fluid balance Decrease consiousness
Strong pulse Weak pulse /not palpable
BP > 20 mmHg BP ≤ 20 mmHg
No RDS / cyanosis RDS / cyanosis (+)
Warm extremities Cold extremities
Diuresis > 1ml/kgBW/H Diuresis < 1ml/kgBW/H
Examine blood sugar
Reduce IVFD (10ml/kgBW/H) Shock (-)
Strict Evaluation IVFD ↑ (15-20 ml/kgBW/H)
Vital sign
Koloid/Plasma
Bleeding sign Shock (+)
(10-20 max 30 ml/kgBW/H)
Diuresis
Correction acidosis
Hb, PCV, Tr
PCV ↓ Evaluation 1 H
Stable 24 H
Fresh WB 10ml/kgBW PCV ↑
 5 ml/kgBW/H
Can repeated Koloid 20ml/kgBW

3 ml/kgBW/H IVFD stop ≤ 48 H 14


COMPLICATIONS
 Electrolyte Imbalance
 Hyponatremia
 Hypocalcemia
 Fluid overload
 Early IVFD
 Hypotonic Solution
 Not ↓ IVFD
 Not use colloidal Sol/Plasma
 Not give blood transf
 Not Calculate IVFD
15
COMPLICATIONS

Signs and Symptoms of fluid overload


 RDS, Dyspnea and Tachypnea
 Massive ascites
 Rapid pulse
 ↓ Pulse pressure
 Crepitation / Ronchi
 Poor tissue perfusion

16
COMPLICATIONS

Management of fluid overload


 Change IV to Dextran 40
 Urinary Catheter
 Furosemide 1 mg/kgBW, IV
 Still shock → Dextran 40, 10 ml/kgBW in 10-15 min
 Record Urine output
 Furosemide may repeat if still RDS
 CVP if not Response furosemide
 Ventilatory support
 Pleural/ peritoneal tapping
17
COMPLICATIONS

Unsual manifestation of DHF


- Less than 5 % of patient
- Encephalopathy/encephalitis
- Hepatic failure
- Renal failure
- Dual infections
- Underlying conditions

18
COMPLICATIONS
Common causes of encephalopathy
 Hepatic encephalopathy
 Severe shock
 Inborn error of metab
 Hepatotoxic drugs
 Underlying liver diseases
 Electrolyte imbalance
 Metabolic distrubance (hypoglycemia)
 Intracranial bleeding
 Cerebral thrombosis / ischemia

19
COMPLICATIONS
Management of DHF hepatic encephalopathy
 Maintain oxygenation
 Prevent ↑ intracranial press:
 Restrict IV
 Furosemidea+/dexamethasone
 ↓ Amonia production
 Vit K1 3-10 mg IV
 Correct metab acidosis
 PRC if indicated
 Antibiotic
 H2 Blocker if massive GI Bleeding
 Avoid unnecessary drugs
 Exchange tranf if needed
 Dyalisis if needed
 Branch - chain aminoacid
20
COMPLICATIONS

DHF patients with renal failure


 Prolonged shock
 Acute hemolysis + Hburia
 G6PD Defficiency
 Hemoglobinopathy
 Management of acute hemolysis + Hb uria
 Transfusion PRC or FWB
 IVFD according the stage
 Alkalinize urine

21
COMPLICATIONS
Dual infections
 Associate:
 GI, Salmonella
 RI, Pneumonia
 Urinary infections
 Skin + Soft tissure Inf
 Nosocomial
 Thrombophlebitis
 Pneuomonia
 UTI (catheter)
 Others
 Transfusion reaction
 Hepatitis
 Massive GI Hem
 Drugs reactions

22
INDICATION FOR DISCHARGE
 Not fever in 24 h
 Good appetite
 Good general condition
 Diuresis
 Normal PCV (38-40)
 ≥ 2 days after shock
 No dyspnea
 Platelet > 50.000/mm³
 No complication
23
CAUSES OF DEATH

 Prolonged shock
 Fluid overload
 Massive bleeding
 Unusual manifestation

24

You might also like